IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Fabino Life Sciences IPO is a Fixed Price IPO listing on BSE SME exchange, with an ipo size of ₹ 3.24 Cr. The company is based in New Delhi and caters to Pharmaceutical sector. Aryaman Financial Services is the merchant banker of Fabino Life Sciences IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 26th November 2021.
Fabino Life Sciences IPO open date is 31st December 2021 and close date is 5th January 2022. IPO Allotment Date is 10th January 2022 and Listing date is 13th January 2022.
IPO
Size:
₹ 3.24 Cr.
Avg IPO Size (Sector Based)
: ₹
21.85 cr.
Sector: Pharmaceutical
SME
IPO so far:
39
Merchant Banker:
Aryaman Financial
SME
IPO by BRLM so far:
86
City:
New Delhi
SME
IPO so far:
154
Revenue (annualised):
₹
4.52
cr. 
PE
Ratio:
133.00x
Average Sector PE Ratio: 20.99x
Fabino Life Sciences IPO size is ₹ 3.24 Cr. with IPO price of ₹ 36.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Aryaman Financial Services Limited is the book-running lead manager of the Fabino Life Sciences IPO. Bigshare Services Private Limited is the Registrar and Market Maker is Aryaman Capital Market Limited for Fabino Life Sciences IPO.
Fabino Life Sciences IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Fabino Life Sciences IPO, based in New Delhi, operates in the Pharmaceutical sector with a focus on Pharmaceutical and wellness products. The company is launching its SME IPO on the BSE SME exchange, using the Fixed Price Issue method. Fabino Life Sciences IPO size is ₹ 3.24 Cr. with fresh issue size of ₹ 3.24 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Fabino Life Sciences IPO is expected to be 10th January 2022, after the finalization of basis of allotment. Investors can check Fabino Life Sciences IPO allotment status on the registrars website, Bigshare Services Private Limited . Fabino Life Sciences IPO refund dates are 11th January 2022.
Fabino Life Sciences IPO is expected to be listed on 13th January 2022.
The upper price band for the Fabino Life Sciences IPO is set at ₹ 36.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Fabino Life Sciences IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Fabino Life Sciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 5th January 2022. After submission, funds are blocked until the basis of allotment of Fabino Life Sciences IPO is finalised.
The merchant banker for Fabino Life Sciences IPO is Aryaman Financial Services Limited . Aryaman Financial Services Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Fabino Life Sciences IPO RHP for further details.
The registrar for Fabino Life Sciences IPO is Bigshare Services Private Limited . Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Fabino Life Sciences IPO through their official website or helpline.
Fabino Life Sciences IPO was subscribed 6.93 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 3.24 Cr.
Avg IPO Size (Sector Based)
:
₹ 21.85 Cr.
Sector: Pharmaceutical
SME
IPO so far:
39
Merchant Banker:
Aryaman Financial
SME
IPO by BRLM so far:
86
City:
New Delhi
SME
IPO so far:
154
Revenue (annualised):
₹ 4.52 cr.
PE
Ratio:
133.00x
Average Sector PE Ratio: 20.99x
Fabino Life Sciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Fabino Life Sciences Financial Review Page
Merchant Banker(s) of Fabino Life Sciences IPO: Aryaman Financial Services Limited
Fabino Life Sciences IPO subscription was 6.93 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Fabino Life Sciences IPO listed at a listing price of 40.35 against the offer price of 36.00.
The current market price of Fabino Life Sciences is 24.75.
Why Us?
